RecruitingNCT07197099
Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease
Evaluation of Therapeutic Plasma Exchange for Immune-Mediated Neurological Diseases in a Sample of Egyptian Patients: An Experience at Al-Azhar University Hospitals
Sponsor
Al-Azhar University
Enrollment
60 participants
Start Date
Jan 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to Evaluation of Therapeutic Plasma Exchange for Immune-Mediated Neurological Diseases in a Sample of Egyptian Patients: An Experience at Al-Azhar University Hospitals, including evaluating clinical response rates and functional improvement.
Eligibility
Inclusion Criteria1
- \. All neurological patients irrespective of age who will undergo TPE. 2.All new and relapse cases that meet the ASFA guidelines and where TPE is the first and/or second line of therapy
Exclusion Criteria3
- \. Individuals with contraindications to therapeutic plasma exchange, such as hemodynamic unstable, hypocalcaemia, allergy to fresh frozen plasma or albumin.
- Patients who will undergo fewer than five cycles of TPE and not complete the procedure.
- Patients with non-neurological disorders.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07197099